[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 4967 followers Created: 2025-07-20 16:23:34 UTC 🦉 Ozempic mentioned in XX% of posts; Wegovy in 18%; Rybelsus—despite FDA approval—only 1%. Daily pill format and adherence challenges likely reduced its visibility. #GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS XXX engagements  **Related Topics** [sny](/topic/sny) [hims](/topic/hims) [pfe](/topic/pfe) [manat](/topic/manat) [$hims](/topic/$hims) [$vani](/topic/$vani) [$zldpf](/topic/$zldpf) [$rhhby](/topic/$rhhby) [Post Link](https://x.com/AponiaAnalytics/status/1946969241652994302)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
aponia_analytics @AponiaAnalytics on x 4967 followers
Created: 2025-07-20 16:23:34 UTC
🦉 Ozempic mentioned in XX% of posts; Wegovy in 18%; Rybelsus—despite FDA approval—only 1%. Daily pill format and adherence challenges likely reduced its visibility.
#GLP1 #Semaglutide $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS
XXX engagements
/post/tweet::1946969241652994302